Daniel B. Smith

2.2k total citations
39 papers, 1.7k citations indexed

About

Daniel B. Smith is a scholar working on Surgery, Family Practice and Economics and Econometrics. According to data from OpenAlex, Daniel B. Smith has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Family Practice and 5 papers in Economics and Econometrics. Recurrent topics in Daniel B. Smith's work include Medication Adherence and Compliance (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Diabetes Treatment and Management (3 papers). Daniel B. Smith is often cited by papers focused on Medication Adherence and Compliance (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Diabetes Treatment and Management (3 papers). Daniel B. Smith collaborates with scholars based in United States, Australia and France. Daniel B. Smith's co-authors include John G. Walt, Joshua S. Benner, Jason Yeaw, Rita J. Balice‐Gordon, Madé Wenten, Elise M. Pelletier, Mohamed Hussein, Jennie H. Best, William H. Herman and Byron J. Hoogwerf and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Daniel B. Smith

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel B. Smith United States 18 501 350 289 254 226 39 1.7k
Gerolamo Bianchi Italy 26 421 0.8× 87 0.2× 362 1.3× 35 0.1× 495 2.2× 81 2.1k
Ulrich M. Vischer Switzerland 28 582 1.2× 638 1.8× 328 1.1× 48 0.2× 99 0.4× 57 2.8k
Xun Zhang Canada 20 772 1.5× 277 0.8× 364 1.3× 25 0.1× 92 0.4× 79 2.3k
Amy Mulick United Kingdom 21 202 0.4× 164 0.5× 51 0.2× 49 0.2× 62 0.3× 55 1.5k
Catherine Norton Ireland 14 1.1k 2.2× 63 0.2× 242 0.8× 49 0.2× 64 0.3× 39 2.3k
P. Grise France 28 160 0.3× 237 0.7× 1.2k 4.2× 57 0.2× 1.6k 7.2× 167 2.9k
John W. Loewy United States 21 374 0.7× 41 0.1× 239 0.8× 170 0.7× 66 0.3× 39 2.3k
Wei Shen China 21 327 0.7× 363 1.0× 601 2.1× 55 0.2× 76 0.3× 55 1.9k
Paul Meisner United States 11 1.4k 2.7× 114 0.3× 381 1.3× 34 0.1× 154 0.7× 14 2.7k
Peter Muscarella United States 29 925 1.8× 88 0.3× 1.5k 5.1× 63 0.2× 117 0.5× 105 3.6k

Countries citing papers authored by Daniel B. Smith

Since Specialization
Citations

This map shows the geographic impact of Daniel B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Smith more than expected).

Fields of papers citing papers by Daniel B. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Smith. The network helps show where Daniel B. Smith may publish in the future.

Co-authorship network of co-authors of Daniel B. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Smith. A scholar is included among the top collaborators of Daniel B. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel B. Smith. Daniel B. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Elizabeth M., Daniel B. Smith, Daniel Henderson, et al.. (2025). Disproportionate Rates of Liver Injury in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor in Queensland, Australia. Gastro Hep Advances. 4(6). 100641–100641.
2.
Crom, Deborah B., Yimei Li, Diego R. Hijano, et al.. (2024). Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors. PubMed. 41(5). 309–314.
3.
Pang, Peter S., Benton R. Hunter, Paul I. Musey, et al.. (2024). Patient Comments and Patient Experience Ratings Are Strongly Correlated With Emergency Department Wait Times. Quality Management in Health Care. 33(3). 192–199. 2 indexed citations
4.
Rogero, Ryan G., Meghan E. Bishop, Brandon J. Erickson, et al.. (2020). The Utilization of Physician Cell Phone Numbers by Patients in an Orthopaedic Surgery Practice. Cureus. 12(4). e7712–e7712. 1 indexed citations
5.
Smith, Daniel B., et al.. (2018). Artigo técnico / Technical article: Bleach plant optimization utilizing novel measurement technologies complemented with advanced process control. 79(2). 65–72. 1 indexed citations
7.
Dore, David D., et al.. (2013). A pooled analysis of exenatide use and risk of acute pancreatitis. Current Medical Research and Opinion. 29(12). 1577–1586. 14 indexed citations
8.
Smith, Daniel B. & Jian Liu. (2013). Branching and capping determine the force–velocity relationships of branching actin networks. Physical Biology. 10(1). 16004–16004. 8 indexed citations
9.
Wenten, Madé, Mohamed Hussein, E.M. Pelletier, et al.. (2012). Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study. Diabetic Medicine. 29(11). 1412–1418. 64 indexed citations
10.
Pelletier, Elise M., et al.. (2012). Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis. Journal of Oncology Practice. 8(3S). 9s–15s. 19 indexed citations
11.
Yeaw, Jason, et al.. (2009). Comparing Adherence and Persistence Across 6 Chronic Medication Classes. Journal of Managed Care Pharmacy. 15(9). 728–740. 462 indexed citations
12.
Smith, Daniel B., et al.. (2009). Near fatal posterior reversible encephalopathy syndrome complicating chronic liver failure and treated by induced hypothermia and dialysis: a case report. Journal of Medical Case Reports. 3(1). 6623–6623. 14 indexed citations
13.
Santiago, Mittermayer B., Murray Baron, Kiyomitsu Miyachi, et al.. (2007). A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clinical Rheumatology. 27(1). 77–83. 72 indexed citations
14.
Kleih, U., et al.. (2003). Improved food crop marketing through appropriate transport for poor farmers in Uganda. Baseline study based on participatory rural appraisals and household questionnaire surveys in nine sub-counties of Iganga, Kasese, and Katakwi districts. 2 indexed citations
15.
Balice‐Gordon, Rita J., Daniel B. Smith, Joshua Goldman, et al.. (2000). Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Annals of Neurology. 47(5). 596–605. 41 indexed citations
16.
Reddy, Sita, Daniel B. Smith, Mark M. Rich, et al.. (1996). Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genetics. 13(3). 325–335. 254 indexed citations
17.
Stedman, Hansell H., Rita J. Balice‐Gordon, Daniel B. Smith, et al.. (1996). In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes. Human Gene Therapy. 7(15). 1907–1914. 123 indexed citations
18.
Smith, Robert A. & Daniel B. Smith. (1995). Does Airway Pressure Release Ventilation Alter Lung Function After Acute Lung Injury?. CHEST Journal. 107(3). 805–808. 11 indexed citations
19.
Hrutfiord, Bjorn F., et al.. (1988). Essential oil of Conyza canadensis. Phytochemistry. 27(6). 1858–1860. 26 indexed citations
20.
Smith, Daniel B., et al.. (1986). Evaluation of the impact of Medicare and Medicaid prospective payment on utilization of Philadelphia area hospitals.. PubMed. 21(4). 529–46. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026